How many insider trades does FilingIQ track for TERN?

FilingIQ tracks 202 Form 4 insider transactions for TERN (Terns Pharmaceuticals, Inc.), covering filings from Feb 9, 2021 onwards. 64 of those were filed in the last 90 days.

Are TERN insiders net buyers or net sellers?

Across the full Form 4 history for TERN, 50 transactions (25%) were open-market purchases and 50 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TERN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TERN in?

Terns Pharmaceuticals, Inc. (TERN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.24B.

TERN insider trading

Healthcare

Terns Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

202

Last 90 days

Buys / sells

25% / 25%

Market cap

$4.24B

About Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.

Company website: www.ternspharma.com

TERN insider activity at a glance

FilingIQ has scored 202 insider transactions for TERN since Feb 9, 2021. The most recent filing in our index is dated May 5, 2026.

Across the full history, 50 open-market purchases and 50 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TERN insider trades is 59.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TERN trades on FilingIQ Raw filings on SEC EDGAR

Latest TERN Form 4 filings

Burroughs Amy L. Chief Executive Officer

S Jan 5, 2026

Vignola Mark J. Chief Financial Officer

S Jan 6, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading TERN

Burroughs Amy L.

30 trades · score 71.0

13F funds holding TERN

Avoro Capital Advisors LLC

$175.74M · 1.7% of AUM

VR Adviser, LLC

$37.75M · 6.4% of AUM

Decheng Capital Management III (Cayman), LLC

$3.59M · 1.2% of AUM

Samsara BioCapital, LLC

$2.40M · 0.5% of AUM

Frequently asked

How many insider trades does FilingIQ track for TERN?: FilingIQ tracks 202 Form 4 insider transactions for TERN (Terns Pharmaceuticals, Inc.), covering filings from Feb 9, 2021 onwards. 64 of those were filed in the last 90 days.
Are TERN insiders net buyers or net sellers?: Across the full Form 4 history for TERN, 50 transactions (25%) were open-market purchases and 50 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TERN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TERN in?: Terns Pharmaceuticals, Inc. (TERN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.24B.

Methodology & sources

Every TERN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.